The agreement covers the future launch of three globally recognized cannabis brands into the UK medical market in the coming months, representing a significant expansion of differentiated cannabinoid product offerings available to UK healthcare professionals and patients. Together, the brands bring internationally established genetics, advanced inhalation technologies, and some of the most recognizable names in the global cannabis industry, introducing entirely new product categories and patient experiences into the regulated UK medical sector.

https://www.mmjdaily.com/article/9841988/somai-signs-uk-agreement-to-launch-cannabis-brands/